
Glimepiride (4mg)
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimiprime 4mg Tablet contains Glimepiride 4mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions primarily by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. Glimepiride enhances peripheral glucose uptake and reduces hepatic glucose output, contributing to its antihyperglycemic effect. This medication is typically prescribed as an adjunct to diet and exercise when these measures alone are insufficient to achieve adequate blood glucose levels. Glimiprime 4mg should be administered once daily with breakfast or the first main meal to optimize absorption and minimize the risk of hypoglycemia. Dosage adjustments should be individualized based on patient response and glycemic targets, with careful monitoring to avoid adverse effects such as hypoglycemia, weight gain, or gastrointestinal disturbances. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or known hypersensitivity to sulfonylureas. Caution is advised in patients with hepatic or renal impairment. Regular monitoring of blood glucose and HbA1c levels is recommended to assess therapeutic efficacy and guide ongoing treatment decisions.
How to use Glimiprime Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimiprime 4mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimiprime 4mg Tablet.
High Risk
Glimiprime 4mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimiprime 4mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimiprime 4mg Tablet may be needed. Please consult your doctor. However, the use of Glimiprime 4mg Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimiprime 4mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimiprime 4mg Tablet
Consult Doctor
Glimiprime 4mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimiprime 4mg Tablet may be needed. Please consult your doctor. Use of Glimiprime 4mg Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimiprime 4mg Tablet

Glimepiride (4mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimiprime 4mg Tablet contains Glimepiride 4mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions primarily by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. Glimepiride enhances peripheral glucose uptake and reduces hepatic glucose output, contributing to its antihyperglycemic effect. This medication is typically prescribed as an adjunct to diet and exercise when these measures alone are insufficient to achieve adequate blood glucose levels. Glimiprime 4mg should be administered once daily with breakfast or the first main meal to optimize absorption and minimize the risk of hypoglycemia. Dosage adjustments should be individualized based on patient response and glycemic targets, with careful monitoring to avoid adverse effects such as hypoglycemia, weight gain, or gastrointestinal disturbances. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or known hypersensitivity to sulfonylureas. Caution is advised in patients with hepatic or renal impairment. Regular monitoring of blood glucose and HbA1c levels is recommended to assess therapeutic efficacy and guide ongoing treatment decisions.
How to use Glimiprime Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimiprime 4mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimiprime 4mg Tablet.
High Risk
Glimiprime 4mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimiprime 4mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimiprime 4mg Tablet may be needed. Please consult your doctor. However, the use of Glimiprime 4mg Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimiprime 4mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimiprime 4mg Tablet
Consult Doctor
Glimiprime 4mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimiprime 4mg Tablet may be needed. Please consult your doctor. Use of Glimiprime 4mg Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimiprime 4mg Tablet













